BACKGROUND: Cardiovascular disease is a common cause of morbidity and death in persons with renal insufficiency. Although 3-hydroxy-3methylglutaryl coenzyme A r...
作者：国际循环网 发布于：2004-08-10
CONTEXT: Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and mortality. However， the optimal strategy and target level for lipid...
BACKGROUND: Lipid-lowering therapy with statins reduces the risk of cardiovascular events， but the optimal level of low-density lipoprotein (LDL) cholesterol i...
BACKGROUND: Lower blood cholesterol concentrations have consistently been found to be strongly associated with lower risks of coronary disease but not with lowe...
CONTEXT: Although cholesterol-reducing treatment has been shown to reduce fatal and nonfatal coronary disease in patients with coronary heart disease (CHD)， it...
CONTEXT: Despite evidence of efficacy of antihypertensive agents in treating hypertensive patients， safety and efficacy of antihypertensive agents for coronary...
专家视角丨高血压管理新篇：余静教授202..
心房颤动患者和动脉粥样硬化患者磁共振..
ESC专访｜郭豫涛教授解析mAFA扩展试验结..
波兰国家注册数据：药物涂层球囊治疗冠..
京公网安备 11010502033353号 增值电信业务经营许可证:京ICP证150541号
